Annual report
7932.TEDINET S100W3MZ
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥49.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥49.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥44.8bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥39.3bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥35.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.6bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥3.6bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.6bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.7bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.6bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥842m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.7bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.7bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.2bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.2bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥2.6bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥70.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥72.4bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥69.6bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥68.4bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥69.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥29.6bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥34.1bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥40.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥38.3bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥35.1bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥34.0bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥33.0bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.6bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥7.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥4.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥815m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥580m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥821m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥917m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥3.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥3.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.7bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥854.46 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥886.04 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥406.79 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥397.95 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,467.11 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥13,853.4 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥13,081.12 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥11,982.71 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥11,617.32 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥11,268.74 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 56.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.0% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.8% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.7% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.3% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.5% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.5% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.0% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 640 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 627 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 611 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 602 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 606 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥29.7bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥30.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥27.9bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥24.8bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥25.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.4bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.5bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.5bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥695m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥620m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.6bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.4bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.8bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥1.8bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥677m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥996m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥57.9bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥59.7bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥58.4bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥58.7bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥60.4bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥24.5bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥27.7bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥33.4bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥32.0bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥29.9bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥29.4bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥28.8bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.2bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥640.17 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥628.42 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥235.6 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥346.61 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,534.71 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥600 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥220 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥11,601.5 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥11,130.7 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥10,383.28 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥10,216.1 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥10,028.47 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 57.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.1% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.0% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.7% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 5.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.3% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.4% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.6% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,889,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,889,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,889,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,889,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,889,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 471 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 449 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 428 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 418 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 416 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 94
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥39m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥174m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥4m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥1.8bn |
| Collagen Casing And Materialreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥174m |
| Collagen Casing And Materialreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥691m |
| Collagen Casing And Materialreportable segment | employees | at 2025-03-31 | 339 pure |
| Collagen Casing And Materialreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥9.3bn |
| Collagen Casing And Materialreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥9.3bn |
| Collagen Casing And Materialreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Cosmeticsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥13m |
| Cosmeticsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥43m |
| Cosmeticsreportable segment | employees | at 2025-03-31 | 54 pure |
| Cosmeticsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥7.7bn |
| Cosmeticsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥7.7bn |
| Cosmeticsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.0bn |
| Foodstuff And Otherreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥208m |
| Foodstuff And Otherreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥86m |
| Foodstuff And Otherreportable segment | employees | at 2025-03-31 | 59 pure |
| Foodstuff And Otherreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥10.6bn |
| Foodstuff And Otherreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥10.6bn |
| Foodstuff And Otherreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥591m |
| Gelatin And Peptide Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥36m |
| Gelatin And Peptide Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥253m |
| Gelatin And Peptide Relatedreportable segment | employees | at 2025-03-31 | 96 pure |
| Gelatin And Peptide Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥13.2bn |
| Gelatin And Peptide Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥13.2bn |
| Gelatin And Peptide Relatedreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥3m |
| Gelatin And Peptide Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Leather Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥15m |
| Leather Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥21m |
| Leather Relatedreportable segment | employees | at 2025-03-31 | 43 pure |
| Leather Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥7.2bn |
| Leather Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥7.2bn |
| Leather Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥210m |
| Real Estate And Leasereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥7m |
| Real Estate And Leasereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥3m |
| Real Estate And Leasereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Real Estate And Leasereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Real Estate And Leasereportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥0 |
| Real Estate And Leasereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥837m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥456m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥49.1bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥49.1bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥4m |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥5.4bn |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥106m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥178m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥15m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥15m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥1.6bn |
| Collagen Casing And Materialreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥1.3bn |
| Collagen Casing And Materialreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥694m |
| Collagen Casing And Materialreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥9.5bn |
| Collagen Casing And Materialreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥9.5bn |
| Collagen Casing And Materialreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥969m |
| Cosmeticsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥15m |
| Cosmeticsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥64m |
| Cosmeticsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥7.6bn |
| Cosmeticsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥7.6bn |
| Cosmeticsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.0bn |
| Foodstuff And Otherreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥106m |
| Foodstuff And Otherreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥51m |
| Foodstuff And Otherreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥9.4bn |
| Foodstuff And Otherreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥9.4bn |
| Foodstuff And Otherreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥424m |
| Gelatin And Peptide Relatedreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥39m |
| Gelatin And Peptide Relatedreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥522m |
| Gelatin And Peptide Relatedreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥13.9bn |
| Gelatin And Peptide Relatedreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥13.9bn |
| Gelatin And Peptide Relatedreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥14m |
| Gelatin And Peptide Relatedreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| Leather Relatedreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥22m |
| Leather Relatedreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥19m |
| Leather Relatedreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥7.6bn |
| Leather Relatedreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥7.6bn |
| Leather Relatedreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥359m |
| Real Estate And Leasereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥3m |
| Real Estate And Leasereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Real Estate And Leasereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Real Estate And Leasereportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥0 |
| Real Estate And Leasereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥849m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥1.5bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥1.4bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥49.1bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥49.0bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥15m |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥5.3bn |
| Collagen Casing And Materialreportable segment | employees | at 2025-03-31 | 300 pure |
| Cosmeticsreportable segment | employees | at 2025-03-31 | 5 pure |
| Foodstuff And Otherreportable segment | employees | at 2025-03-31 | 30 pure |
| Gelatin And Peptide Relatedreportable segment | employees | at 2025-03-31 | 93 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,829
| Item | Context | Value | Unit |
|---|---|---|---|
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.4297 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 415000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.1445 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 222000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0774 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 116000 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0405 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 100000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0348 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 96000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0336 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 84000 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0294 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 74000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0260 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 69000 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0243 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 60000 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0208 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 50000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0174 | |
| Number of shares held | CurrentYearInstant | 1290000 | |
| Shareholding ratio | CurrentYearInstant | 0.4487 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 13200 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 2867200 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 28672 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 8600 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 2889000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 28672 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 13200 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 13200 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0046 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 13200 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 13200 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0046 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 1725000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 600 | |
| Number of male directors and other officers | FilingDateInstant | 11 | |
| Number of female directors and other officers | FilingDateInstant | 1 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.083 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01120-000ItoTakaoMember | 28088 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01120-000ItoYukoMember | 622 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01120-000InoueYoshiyukiMember | 1210 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01120-000FukasawaYukihiroMember | 800 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |